Taffic Tablet

Bottle

4.5 (154)

3,500

Taffic Tablet is a combination antiretroviral medicine used to treat HIV-1 infection in adults. It contains bictegravir, emtricitabine, and tenofovir alafenamide, which work together to prevent the virus from multiplying by blocking key enzymes required for viral replication. This helps reduce the viral load, maintain immune function, and slow the progression of HIV infection. The tablet should be taken exactly as prescribed by your doctor. Regular monitoring is recommended to ensure treatment effectiveness and detect any possible side effects early.

Description

Introduction Of Taffic Tablet:

A combination drug known as Taffic, which comes in dosages of bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, is used to treat HIV-1 infection in adults. It is precisely categorised as a combination of an integrase strand transfer inhibitor (bictegravir) and two nucleoside reverse transcriptase inhibitors (emtricitabine and tenofovir alafenamide) and is a member of the pharmacological class known as antiretrovirals.

Mechanism Of Action Of Taffic Tablet:

Bictegravir, an inhibitor of integrase strand transfer, operates by preventing the HIV integrase enzyme from doing its job. This enzyme is in charge of integrating viral DNA into the host cell’s DNA. Bictegravir stops the virus from replicating by preventing this process.

The nucleoside reverse transcriptase inhibitors emtricitabine and tenofovir alafenamide function by obstructing the reverse transcriptase enzyme, which is essential for the virus to reproduce. While tenofovir alafenamide is transformed into its active form (tenofovir), which functions as a chain terminator for viral DNA, emtricitabine inhibits the action of reverse transcriptase.

Use Of Taffic Tablet:

Taffic’s main application is the treatment of adult HIV-1 infection. It is frequently taken along with other antiretroviral drugs as a combination therapy. Reducing viral load, maintaining immunological function, and delaying the course of HIV-related diseases are the goals of treatment.

Side Effect Of Taffic Tablet:

Like any drug, Taffic has potential negative effects. Unusual nightmares, diarrhoea, headaches, and exhaustion are a few of the more typical adverse effects. Additionally, it may alter bone mineral density and kidney function. Some people could have more severe side effects, like allergic responses, liver issues, or lactic acidosis (an accumulation of lactic acid in the blood) are possible causes. To decide the best course of action, it’s crucial to address any adverse effects with a healthcare professional.

Contact Us

Info Table
Strength 50/200/25 mg
Pack Size 30 tablets
Brand taffic
Composition Bictegravir/Emtricitabine/TAF
Usage HIV Treatment
Form Tablet
Prescription Type Prescription
Manufacturer Gilead Sciences
Shelf Life 24 months
Vendor Info
Benefits
Reviews

Description

Introduction Of Taffic Tablet:

A combination drug known as Taffic, which comes in dosages of bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, is used to treat HIV-1 infection in adults. It is precisely categorised as a combination of an integrase strand transfer inhibitor (bictegravir) and two nucleoside reverse transcriptase inhibitors (emtricitabine and tenofovir alafenamide) and is a member of the pharmacological class known as antiretrovirals.

Mechanism Of Action Of Taffic Tablet:

Bictegravir, an inhibitor of integrase strand transfer, operates by preventing the HIV integrase enzyme from doing its job. This enzyme is in charge of integrating viral DNA into the host cell’s DNA. Bictegravir stops the virus from replicating by preventing this process.

The nucleoside reverse transcriptase inhibitors emtricitabine and tenofovir alafenamide function by obstructing the reverse transcriptase enzyme, which is essential for the virus to reproduce. While tenofovir alafenamide is transformed into its active form (tenofovir), which functions as a chain terminator for viral DNA, emtricitabine inhibits the action of reverse transcriptase.

Use Of Taffic Tablet:

Taffic’s main application is the treatment of adult HIV-1 infection. It is frequently taken along with other antiretroviral drugs as a combination therapy. Reducing viral load, maintaining immunological function, and delaying the course of HIV-related diseases are the goals of treatment.

Side Effect Of Taffic Tablet:

Like any drug, Taffic has potential negative effects. Unusual nightmares, diarrhoea, headaches, and exhaustion are a few of the more typical adverse effects. Additionally, it may alter bone mineral density and kidney function. Some people could have more severe side effects, like allergic responses, liver issues, or lactic acidosis (an accumulation of lactic acid in the blood) are possible causes. To decide the best course of action, it’s crucial to address any adverse effects with a healthcare professional.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Taffic Tablet”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Taffic Tablet used for?
Taffic Tablet is a complete, once-daily combination antiretroviral regimen used to treat HIV-1 infection in adults. It contains bictegravir, emtricitabine, and tenofovir alafenamide, working together to reduce the amount of HIV in the body.
Bictegravir blocks the HIV integrase enzyme, preventing viral DNA from integrating into host cells. Emtricitabine and tenofovir alafenamide block the reverse transcriptase enzyme the virus needs to replicate. Together, these actions lower viral load and help preserve immune function.
It should be taken once daily, exactly as prescribed, at the same time each day for consistent effectiveness. Missing doses can allow the virus to become resistant to treatment, so consistent daily use is essential.
Common side effects include headache, diarrhea, nausea, fatigue, and unusual dreams. It may also affect bone mineral density and kidney function over time, so regular monitoring is typically recommended.
This medication should not be used to treat hepatitis B virus (HBV) infection. Patients should be tested for HBV before starting treatment, as stopping this medication in someone with HBV coinfection can cause the liver condition to suddenly worsen, requiring close medical monitoring if treatment is discontinued.
Each tablet contains Bictegravir 50mg, Emtricitabine 200mg, and Tenofovir Alafenamide 25mg, manufactured by Gilead Sciences, supplied as 30 tablets per bottle.

Related products